Copious Production of SARS-CoV Nucleocapsid Protein Employing Codon Optimized Synthetic Gene

Overview

Journal J Virol Methods

Specialty Microbiology

Date 2006 Aug 15

PMID 16904198

Citations 15

Authors

Dipankar Das

Mavanur R Suresh

Affiliations

Soon will be listed here.

Abstract

The severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid protein (NP) is one of the predominant antigenic protein and the most abundant shed antigen throughout the SARS-CoV infection. This feature makes it a suitable molecular target for diagnostic applications. In this study the full length codon optimized NP gene and its subfragment gene segment was cloned in a bacterial expression vector. The full length NP could be expressed in E. coli at very high level within inclusion bodies. The inclusion bodies were successfully solubilized, purified under denaturing conditions employing IMAC column and refolded. The non-glycosylated NP was used to immunize mice for hybridoma development. The polyclonal antiserum from animals immunized with this recombinant NP protein was found to specifically recognize the NP and its subfragments, thus demonstrating the immunogenic nature of the recombinant protein. The NP antigen or a subfragment could be useful for developing a sensitive serum diagnostic assay to monitor SARS-CoV outbreaks by detecting the early human anti-SARS antibodies. In addition, the availability of the NP fragments could facilitate epitope mapping of anti-NP monoclonals for identifying suitable sandwich pairs.

Citing Articles

Dealing with inconclusive SARS-CoV-2 PCR samples-Our experience.

Stoykova Z, Kostadinova T, Todorova T, Niyazi D, Bozhkova M, Bizheva S PLoS One. 2022; 17(5):e0268187.

PMID: 35560147 PMC: 9106147. DOI: 10.1371/journal.pone.0268187.

High level SARS-CoV-2 nucleocapsid refolding using mild condition for inclusion bodies solubilization: Application of high pressure at pH 9.0.

Chura-Chambi R, Prieto-da-Silva A, Di Lela M, Oliveira J, Abreu P, Meireles L PLoS One. 2022; 17(2):e0262591.

PMID: 35113919 PMC: 8812862. DOI: 10.1371/journal.pone.0262591.

Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19.

Campello E, Radu C, Simion C, Spiezia L, Bulato C, Gavasso S Front Cell Dev Biol. 2022; 9:770463.

PMID: 35111751 PMC: 8801799. DOI: 10.3389/fcell.2021.770463.

A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests.

Klausberger M, Duerkop M, Haslacher H, Wozniak-Knopp G, Cserjan-Puschmann M, Perkmann T EBioMedicine. 2021; 67:103348.

PMID: 33906067 PMC: 8099623. DOI: 10.1016/j.ebiom.2021.103348.

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.

Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel S, Murray J Emerg Infect Dis. 2020; 26(6):1266-1273.

PMID: 32160149 PMC: 7258473. DOI: 10.3201/eid2606.200516.

References

Tang T, Wu M, Chen S, Hou M, Hong M, Pan F . Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses. Proteomics. 2005; 5(4):925-37. PMC: 7167620. DOI: 10.1002/pmic.200401204. View

Lau S, Woo P, Wong B, Tsoi H, Woo G, Poon R . Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay. J Clin Microbiol. 2004; 42(7):2884-9. PMC: 446266. DOI: 10.1128/JCM.42.7.2884-2889.2004. View

Zoller L, Yang S, Gott P, Bautz E, Darai G . A novel mu-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome. J Clin Microbiol. 1993; 31(5):1194-9. PMC: 262902. DOI: 10.1128/jcm.31.5.1194-1199.1993. View

Che X, Qiu L, Pan Y, Wen K, Hao W, Zhang L . Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J Clin Microbiol. 2004; 42(6):2629-35. PMC: 427886. DOI: 10.1128/JCM.42.6.2629-2635.2004. View

Leung D, Tam F, Ma C, Chan P, Cheung J, Niu H . Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis. 2004; 190(2):379-86. PMC: 7110057. DOI: 10.1086/422040. View

Chang M, Lu Y, Ho S, Wu C, Wei T, Chen C . Antibody detection of SARS-CoV spike and nucleocapsid protein. Biochem Biophys Res Commun. 2004; 314(4):931-6. PMC: 7111193. DOI: 10.1016/j.bbrc.2003.12.195. View

Wang Y, Wu X, Wang Y, Li B, Zhou H, Yuan G . Low stability of nucleocapsid protein in SARS virus. Biochemistry. 2004; 43(34):11103-8. DOI: 10.1021/bi049194b. View

Jiang S, Chen T, Yang J, Hsiung C, Su I, Liu Y . Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction. Clin Infect Dis. 2003; 38(2):293-6. PMC: 7107825. DOI: 10.1086/380841. View

Lin Y, Shen X, Yang R, Li Y, Ji Y, He Y . Identification of an epitope of SARS-coronavirus nucleocapsid protein. Cell Res. 2003; 13(3):141-5. PMC: 7091728. DOI: 10.1038/sj.cr.7290158. View

10.

Tan Y, Goh P, Fielding B, Shen S, Chou C, Fu J . Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol. 2004; 11(2):362-71. PMC: 371215. DOI: 10.1128/cdli.11.2.362-371.2004. View

11.

Konishi E, Mason P, Shope R . Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis. J Med Virol. 1996; 48(1):76-9. DOI: 10.1002/(SICI)1096-9071(199601)48:1<76::AID-JMV12>3.0.CO;2-4. View

12.

Duan S, Zhao X, Wen R, Huang J, Pi G, Zhang S . Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003; 16(3):246-55. View

13.

Cao S, Wang H, Luhur A, Wong S . Yeast expression and characterization of SARS-CoV N protein. J Virol Methods. 2005; 130(1-2):83-8. PMC: 7112830. DOI: 10.1016/j.jviromet.2005.06.010. View

14.

Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel D . JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005; 33(Web Server issue):W526-31. PMC: 1160137. DOI: 10.1093/nar/gki376. View

15.

He Q, Chong K, Chng H, Leung B, Ling A, Wei T . Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome. Clin Diagn Lab Immunol. 2004; 11(2):417-22. PMC: 371214. DOI: 10.1128/cdli.11.2.417-422.2004. View

16.

Sohn M, Chong Y, Chang J, Lee Y . Overexpression and simple purification of human immunodeficiency virus-1 gag epitope derived from a recombinant antigen in E. coli and its use in ELISA. J Biotechnol. 1994; 34(2):149-55. DOI: 10.1016/0168-1656(94)90084-1. View

17.

Shi Y, Yi Y, Li P, Kuang T, Li L, Dong M . Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J Clin Microbiol. 2003; 41(12):5781-2. PMC: 309018. DOI: 10.1128/JCM.41.12.5781-5782.2003. View

18.

Das D, Kriangkum J, Nagata L, Fulton R, Suresh M . Development of a biotin mimic tagged ScFv antibody against western equine encephalitis virus: bacterial expression and refolding. J Virol Methods. 2004; 117(2):169-77. DOI: 10.1016/j.jviromet.2004.01.008. View

19.

Hiscox J, Cavanagh D, Britton P . Quantification of individual subgenomic mRNA species during replication of the coronavirus transmissible gastroenteritis virus. Virus Res. 1995; 36(2-3):119-30. PMC: 7134076. DOI: 10.1016/0168-1702(94)00108-o. View

20.

Chan P, Ng K, Chan R, Lam R, Chow V, Hui M . Immunofluorescence assay for serologic diagnosis of SARS. Emerg Infect Dis. 2004; 10(3):530-2. PMC: 3322771. DOI: 10.3201/eid1003.030493. View